Table: Oncolys Biopharma -2025 parent results

Oncolys Biopharma

06/02/2026 06:01

Feb 6 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          28 mln          31 mln                                
               (-9.0 pct)      (-50.2 pct)                             
  Operating     loss 2.02       loss 1.68                              
  Recurring     loss 2.05       loss 1.66                              
  Net           loss 2.06       loss 1.68                              
  EPS        loss 80.00 yen  loss 77.17 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T